PureTech Systems Inc., a provider of geospatial AI-boosted video analytics for wide-area perimeter and border security, is proud to announce the integration of its patented PureActiv software with ...
PureTech Systems Inc. today announced the release of its new Interface Control Document (ICD). This essential document provides detailed information on the interfacing requirements necessary for ...
PureTech’s Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome ...
PureTech Health plc (NASDAQ:PRTC) stock is up on Monday, after the company announced results from ELEVATE IPF Phase 2b trial of deupirfenidone (LYT-100) for idiopathic pulmonary fibrosis (IPF). The ...
PureTech Health (PRTC) announced the completion of the End-of-Phase 2 meeting with the FDA regarding the development of deupirfenidone, or ...
PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and ...
BOSTON--(BUSINESS WIRE)-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with ...
BELLE, W.Va.--(BUSINESS WIRE)--PureTech Scientific LLC (PureTech), a global leader in glycolic acid synthesis and technology, today announced the appointment of industry veteran Matthew Smith as Vice ...
Raju Kucherlapati, PhD, distinguished Professor of Medicine at Harvard Medical School, has transitioned to the role of Chair of the Board of Directors on a permanent basis Dr. Kucherlapati commented: ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The leadership change comes as ...
Feedback from U.S. Food and Drug Administration (FDA) supports advancement into a pivotal Phase 3 trial and a 505(b)(2) regulatory pathway Phase 3 SURPASS-IPF trial remains on track to be initiated by ...
Hello, everyone, and thank you for joining the PureTech Health 2025 Half Year Earnings Webcast. My name is Sami, and I'll be coordinating your call today. [Operator Instructions] I would now like to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results